Hepatitis A, B, and C: Learn the Differences
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
IRRITABLE BOWEL SYNDROME by Michael Sperling MD
IRRITABLE BOWEL SYNDROME By Michael Sperling MD Irritable bowel syndrome (IBS) involves vague symptoms of abdominal pain, diarrhea, constipation, gas and bloating for which there is no understandable cause. Incredibly, IBS affects up to 20% of the population but only three- quarters of those people actually seek medical attention. It is the second most common reason for work absenteeism. Irritable bowel symptoms may also be related to other complaints such as belching, heartburn, swallowing problems, fullness after eating, nausea, frequent urination, painful menstruation and pain during intercourse. Extremely severe cases can sometimes be related to a history of traumatic abuse. Some common associations or factors: Michael Sperling, MD 1. ‘Spastic colon’ is frequently found along with irritable bowel syndrome. Spastic colon consists of painful muscle contractions which can be relieved by bulk agents or anti- spasm drugs. 2. Post-infectious IBS occurs when irritable bowel follows a gastrointestinal infection, such as the stomach flu. These recurrent symptoms can last up to two years. 3. Stress and anxiety can worsen IBS symptoms so occasionally anti-anxiety agents may be helpful. 4. Food intolerances classically worsen symptoms of irritable bowel in some people. Common “offending foods” include lactose, legumes (beans) and cruciferous vegetables like brussel sprouts, cauliflower, broccoli and cabbage. 5. Hypersensitivity of the bowel wall: Normal colon activity is not usually noticed however in “visceral hypersensitivity”, the bowel wall reacts painfully to normal activity. This condition may be helped by the use of low dose antidepressants, which can block these painful stimuli. Careful and selective testing of patients with these symptoms and the development of a long-term doctor/patient relationship is the key to diagnosing and managing these symptoms. -
Food Handler Exclusion Guidelines
Food Handler Exclusion Guidelines A guide for determining suitable exclusion periods for ill food handlers November 2017 Food handler exclusion guidelines Published by the State of Queensland (Queensland Health), November 2017 This document is licensed under a Creative Commons Attribution 3.0 Australia licence. To view a copy of this licence, visit creativecommons.org/licenses/by/3.0/au © State of Queensland (Queensland Health) 2017 You are free to copy, communicate and adapt the work, as long as you attribute the State of Queensland (Queensland Health). For more information contact: Food Safety Standards and Regulation, Department of Health, GPO Box 48, Brisbane QLD 4001, email [email protected], phone 07 3328 9310. An electronic version of this document is available at www.health.qld.gov.au. Disclaimer: The content presented in this publication is distributed by the Queensland Government as an information source only. The State of Queensland makes no statements, representations or warranties about the accuracy, completeness or reliability of any information contained in this publication. The State of Queensland disclaims all responsibility and all liability (including without limitation for liability in negligence) for all expenses, losses, damages and costs you might incur as a result of the information being inaccurate or incomplete in any way, and for any reason reliance was placed on such information. Food Handler Exclusion Guidelines - ii - Contents 1. Introduction ............................................................................................... -
PEDIARIX Is a Vaccine
HIGHLIGHTS OF PRESCRIBING INFORMATION • If Guillain-Barré syndrome occurs within 6 weeks of receipt of a prior These highlights do not include all the information needed to use vaccine containing tetanus toxoid, the decision to give PEDIARIX should PEDIARIX safely and effectively. See full prescribing information for be based on potential benefits and risks. (5.2) PEDIARIX. • The tip caps of the prefilled syringes contain natural rubber latex which may cause allergic reactions. (5.3) PEDIARIX [Diphtheria and Tetanus Toxoids and Acellular Pertussis • Syncope (fainting) can occur in association with administration of Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus injectable vaccines, including PEDIARIX. Procedures should be in place Vaccine], Suspension for Intramuscular Injection to avoid falling injury and to restore cerebral perfusion following Initial U.S. Approval: 2002 syncope. (5.4) • If temperature ≥105°F, collapse or shock-like state, or persistent, ----------------------------- INDICATIONS AND USAGE ---------------------------- PEDIARIX is a vaccine indicated for active immunization against diphtheria, inconsolable crying lasting ≥3 hours have occurred within 48 hours after tetanus, pertussis, infection caused by all known subtypes of hepatitis B virus, receipt of a pertussis-containing vaccine, or if seizures have occurred and poliomyelitis. PEDIARIX is approved for use as a 3-dose series in infants within 3 days after receipt of a pertussis-containing vaccine, the decision born of hepatitis B surface antigen (HBsAg)-negative mothers. PEDIARIX to give PEDIARIX should be based on potential benefits and risks. (5.5) may be given as early as 6 weeks of age through 6 years of age (prior to the • For children at higher risk for seizures, an antipyretic may be 7th birthday). -
Viral Hepatitis Testing Effective Date: January 1, 2012
Viral Hepatitis Testing Effective Date: January 1, 2012 Scope This guideline provides guidance for the use of laboratory tests to diagnose acute and chronic viral hepatitis in adults (> 19 years) in the primary care setting. General Considerations for Ordering Laboratory Tests Prior to ordering tests for hepatitis, consider the patient’s history, age, risk factors (see below), hepatitis vaccination status, and any available previous hepatitis test results. Risk Factors for Viral Hepatitis include: • Substance use (includes sharing drug snorting, smoking or injection equipment) • High-risk sexual activity or sexual partner with viral hepatitis • Travel to or from high-risk hepatitis endemic areas or exposure during a local outbreak • Immigration from hepatitis B and/or C endemic countries • Household contact with an infected person especially if personal items (e.g., razors, toothbrushes, nail clippers) are shared • Recipient of unscreened blood products* • Needle-stick injury or other occupational exposure (e.g., healthcare workers) • Children born to mothers with chronic hepatitis B or C infection • Attendance at daycare • Contaminated food or water (hepatitis A only) • Tattoos and body piercing • History of incarceration • HIV or other sexually transmitted infection • Hemodialysis *screening of donated blood products for hepatitis C (anti-HCV) began in 1990 in Canada.1 Types of Viral Hepatitis Hepatitis A: causes acute but not chronic hepatitis Hepatitis B: causes acute and chronic hepatitis Hepatitis C: causes chronic hepatitis but rarely manifests as acute hepatitis Hepatitis D: rare and only occurs in patients infected with hepatitis B Hepatitis E: clinically similar to hepatitis A, mostly restricted to endemic areas and occasionally causes chronic infection in immunosuppressed people Others: e.g. -
Stomach Flu (Viral Gastroenteritis)
Stomach Flu (Viral Gastroenteritis) The stomach flu (also called viral gastroenteritis) is caused by a virus (rotavirus, adenovirus, Norwalk virus to name a few) that affect the stomach and small intestines. It may come on suddenly or over the course of a few hours. The illness is usually brief, lasting 24-72 hours. Symptoms include: Nausea Vomiting Stomach cramps Diarrhea Mild fever Fatigue Body Chills/Sweats Loss of appetite Muscle aches To help take care of yourself: • The best thing to do is to let your stomach rest from solid foods. • Sip on clear liquids (Hi-C, apple, cranberry, and grape juices, Jell-O, Gatorade- type liquids and ginger-ale or ginger tea). There are special properties in ginger that help soothe the stomach. It is extremely important to keep up your hydration. Water is great for hydration but Gatorade-type products are better because they will restore your electrolytes (Sodium, Potassium and Chloride) which are essential for body functions. You may "stir" the bubbles out of the soda if the carbonation is harsh on your stomach. • Once you have not vomited for a few hours and your stomach is feeling better, you may start to eat solid foods. You may try crackers, plain noodles, eggs, broth, pretzels and yogurt. • The BRAT diet (Bananas, Rice, Applesauce & Toast) includes foods that are low in fiber and are easily digested. • Stay away from dairy products, citric (including orange and grapefruit juices), tomato-based & spicy foods. • SLOWLY increase your dietary intake to include fruits, vegetables and meat once symptoms are gone (usually over 2-3 days). -
Prevention & Control of Viral Hepatitis Infection
Prevention & Control of Viral Hepatitis Infection: A Strategy for Global Action © World Health Organization 2011. All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. Table of contents Disease burden 02 What is viral hepatitis? 05 Prevention & control: a tailored approach 06 Global Achievements 08 Remaining challenges 10 World Health Assembly: a mandate for comprehensive prevention & control 13 WHO goals and strategy -
The Role of Hepatitis C Virus in Hepatocellular Carcinoma U
Viruses in cancer cell plasticity: the role of hepatitis C virus in hepatocellular carcinoma U. Hibner, D. Gregoire To cite this version: U. Hibner, D. Gregoire. Viruses in cancer cell plasticity: the role of hepatitis C virus in hepato- cellular carcinoma. Contemporary Oncology, Termedia Publishing House, 2015, 19 (1A), pp.A62–7. 10.5114/wo.2014.47132. hal-02187396 HAL Id: hal-02187396 https://hal.archives-ouvertes.fr/hal-02187396 Submitted on 2 Jun 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution - NonCommercial - ShareAlike| 4.0 International License Review Viruses are considered as causative agents of a significant proportion of human cancers. While the very Viruses in cancer cell plasticity: stringent criteria used for their clas- sification probably lead to an under- estimation, only six human viruses the role of hepatitis C virus are currently classified as oncogenic. In this review we give a brief histor- in hepatocellular carcinoma ical account of the discovery of on- cogenic viruses and then analyse the mechanisms underlying the infectious causes of cancer. We discuss viral strategies that evolved to ensure vi- Urszula Hibner1,2,3, Damien Grégoire1,2,3 rus propagation and spread can alter cellular homeostasis in a way that increases the probability of oncogen- 1Institut de Génétique Moléculaire de Montpellier, CNRS, UMR 5535, Montpellier, France ic transformation and acquisition of 2Université Montpellier 2, Montpellier, France stem cell phenotype. -
Diphtheria, Tetanus, Pertussis, Polio, Hib and Hepatitis B Vaccine for Babies and Children
Diphtheria, Tetanus, Pertussis, Polio, Hib and Hepatitis B vaccine for babies and children This leaflet tells you about the DTaP/IPV/Hib/ HepB vaccine, also known as “6 in 1” as it protects against six diseases, diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type b and hepatitis B (HepB) disease. What does the vaccine protect against? Diphtheria Diphtheria is a serious disease that usually begins with a sore throat and can quickly cause breathing problems. It can damage the heart and nervous system and, in severe cases, can kill. Before diphtheria vaccine was introduced in the UK, there were up to 70,000 cases of diphtheria and around 5,000 deaths a year. Diphtheria can be spread from person to person through close contact. Tetanus Tetanus is a disease affecting the nervous system which can cause muscle spasms and breathing problems and can kill. It is caused when germs found in soil and manure get into the body through wounds or burns. Tetanus cannot be passed from person to person. 2 Published June 2018 Pertussis (whooping cough) Whooping cough is a disease that can cause long bouts of coughing and choking, making it hard to breathe. It can last for up to 10 weeks and babies under one year of age are most at risk. The disease is very serious and can kill. Before the pertussis vaccine was introduced, the average number of cases reported each year in the UK was 120,000 and 92 children died in the year before the vaccine was introduced. Whooping cough is usually spread by coughs and sneezes. -
Appendicitis
Appendicitis Your child has abdominal pain, it might be appendicitis. Appendicitis is swelling or infection in the appendix. The appendix is a small organ attached to the large intestine. Appendicitis usually develops over 12-24 hours. It has symptoms such as abdominal pain, nausea, vomiting, fever, and loss of appetite. Most importantly, pain that continues, worsens and moves to the right lower side of the abdomen is common in appendicitis. Appendicitis is the most common childhood “emergency” that must be treated in a timely manner. However, it’s important to know that many conditions have symptoms similar to appendicitis but don’t require surgery. At Hasbro Children’s Hospital (HCH), we evaluate your child’s abdominal pain to determine if appendicitis is the cause. That way, we avoid unnecessary operations. What happens now? Your child will be well cared for. First your child will be seen in the HCH emergency department (ED) by a nurse and doctor trained in pediatric emergency medicine. If necessary, your child will have tests that include blood work and a urinalysis. Your child’s pain will be managed with intravenous (IV) pain medication. Your child will not be allowed to eat or drink and may receive fluids through an intravenous line. Members of the pediatric surgical team will examine your child to help determine whether your child has appendicitis or another condition. We will perform a painless ultrasound on your child and the ultrasound images will be read by pediatric radiology doctors with advanced training in imaging children. Usually, ultrasound is the only imaging required but sometimes an MRI may be needed as well. -
Chronic Viral Hepatitis in a Cohort of Inflammatory Bowel Disease
pathogens Article Chronic Viral Hepatitis in a Cohort of Inflammatory Bowel Disease Patients from Southern Italy: A Case-Control Study Giuseppe Losurdo 1,2 , Andrea Iannone 1, Antonella Contaldo 1, Michele Barone 1 , Enzo Ierardi 1 , Alfredo Di Leo 1,* and Mariabeatrice Principi 1 1 Section of Gastroenterology, Department of Emergency and Organ Transplantation, University “Aldo Moro” of Bari, 70124 Bari, Italy; [email protected] (G.L.); [email protected] (A.I.); [email protected] (A.C.); [email protected] (M.B.); [email protected] (E.I.); [email protected] (M.P.) 2 Ph.D. Course in Organs and Tissues Transplantation and Cellular Therapies, Department of Emergency and Organ Transplantation, University “Aldo Moro” of Bari, 70124 Bari, Italy * Correspondence: [email protected]; Tel.: +39-080-559-2925 Received: 14 September 2020; Accepted: 21 October 2020; Published: 23 October 2020 Abstract: We performed an epidemiologic study to assess the prevalence of chronic viral hepatitis in inflammatory bowel disease (IBD) and to detect their possible relationships. Methods: It was a single centre cohort cross-sectional study, during October 2016 and October 2017. Consecutive IBD adult patients and a control group of non-IBD subjects were recruited. All patients underwent laboratory investigations to detect chronic hepatitis B (HBV) and C (HCV) infection. Parameters of liver function, elastography and IBD features were collected. Univariate analysis was performed by Student’s t or chi-square test. Multivariate analysis was performed by binomial logistic regression and odds ratios (ORs) were calculated. We enrolled 807 IBD patients and 189 controls. Thirty-five (4.3%) had chronic viral hepatitis: 28 HCV (3.4%, versus 5.3% in controls, p = 0.24) and 7 HBV (0.9% versus 0.5% in controls, p = 0.64). -
Rational Engineering of HCV Vaccines for Humoral Immunity
viruses Review To Include or Occlude: Rational Engineering of HCV Vaccines for Humoral Immunity Felicia Schlotthauer 1,2,†, Joey McGregor 1,2,† and Heidi E Drummer 1,2,3,* 1 Viral Entry and Vaccines Group, Burnet Institute, Melbourne, VIC 3004, Australia; [email protected] (F.S.); [email protected] (J.M.) 2 Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3000, Australia 3 Department of Microbiology, Monash University, Clayton, VIC 3800, Australia * Correspondence: [email protected]; Tel.: +61-392-822-179 † These authors contributed equally to this work. Abstract: Direct-acting antiviral agents have proven highly effective at treating existing hepatitis C infections but despite their availability most countries will not reach the World Health Organization targets for elimination of HCV by 2030. A prophylactic vaccine remains a high priority. Whilst early vaccines focused largely on generating T cell immunity, attention is now aimed at vaccines that gen- erate humoral immunity, either alone or in combination with T cell-based vaccines. High-resolution structures of hepatitis C viral glycoproteins and their interaction with monoclonal antibodies isolated from both cleared and chronically infected people, together with advances in vaccine technologies, provide new avenues for vaccine development. Keywords: glycoprotein E2; vaccine development; humoral immunity Citation: Schlotthauer, F.; McGregor, J.; Drummer, H.E To Include or 1. Introduction Occlude: Rational Engineering of HCV Vaccines for Humoral Immunity. The development of direct-acting antiviral agents (DAA) with their ability to cure Viruses 2021, 13, 805. https:// infection in >95% of those treated was heralded as the key to eliminating hepatitis C globally. -
Zoonotic Diseases Fact Sheet
ZOONOTIC DISEASES FACT SHEET s e ion ecie s n t n p is ms n e e s tio s g s m to a a o u t Rang s p t tme to e th n s n m c a s a ra y a re ho Di P Ge Ho T S Incub F T P Brucella (B. Infected animals Skin or mucous membrane High and protracted (extended) fever. 1-15 weeks Most commonly Antibiotic melitensis, B. (swine, cattle, goats, contact with infected Infection affects bone, heart, reported U.S. combination: abortus, B. suis, B. sheep, dogs) animals, their blood, tissue, gallbladder, kidney, spleen, and laboratory-associated streptomycina, Brucellosis* Bacteria canis ) and other body fluids causes highly disseminated lesions bacterial infection in tetracycline, and and abscess man sulfonamides Salmonella (S. Domestic (dogs, cats, Direct contact as well as Mild gastroenteritiis (diarrhea) to high 6 hours to 3 Fatality rate of 5-10% Antibiotic cholera-suis, S. monkeys, rodents, indirect consumption fever, severe headache, and spleen days combination: enteriditis, S. labor-atory rodents, (eggs, food vehicles using enlargement. May lead to focal chloramphenicol, typhymurium, S. rep-tiles [especially eggs, etc.). Human to infection in any organ or tissue of the neomycin, ampicillin Salmonellosis Bacteria typhi) turtles], chickens and human transmission also body) fish) and herd animals possible (cattle, chickens, pigs) All Shigella species Captive non-human Oral-fecal route Ranges from asymptomatic carrier to Varies by Highly infective. Low Intravenous fluids primates severe bacillary dysentery with high species. 16 number of organisms and electrolytes, fevers, weakness, severe abdominal hours to 7 capable of causing Antibiotics: ampicillin, cramps, prostration, edema of the days.